COMMUNIQUÉS West-GlobeNewswire

Fortress Biotech Announces Publication of Preclinical Data on AAV-ATP7A Gene Therapy Combined with CUTX-101 (Copper Histidinate) for Menkes Disease in Molecular Therapy: Methods & Clinical Development

12/09/2018 - 14:30

NEW YORK, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

Stealth Mark and Sunshine Minting, Inc. Form Strategic Alliance

12/09/2018 - 14:30

Introducing the Next Generation of Stealth Mark, Formula C2-4:18 HOFFMAN ESTATES, IL , Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Wellness Center USA, Inc.’s (OTCQB: WCUI) wholly-owned subsidiary, StealthCo, [...]

eUnity Smartviewer Helps DocPanel Create Disruptive Radiology Marketplace Experience

12/09/2018 - 14:20

WATERLOO, Ontario, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Client Outlook, a leading provider of FDA Class II enterprise diagnostic and clinical image viewing solutions, announced today their partnership with DocPanel [...]

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

12/09/2018 - 14:14

FT. MYERS, Fla., Sept. 12, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has been awarded a group purchasing agreement [...]

Pediapharm annonce des acquisitions transformatrices et un placement de 60 millions de dollars de reçus de souscription

12/09/2018 - 14:08

NON DESTINÉ À LA DISTRIBUTION AUX AGENCES DE PRESSE AMÉRICAINES NI À LA DIFFUSION AUX ÉTATS-UNIS LE NON-RESPECT DE CETTE RESTRICTION PEUT CONSTITUER UNE VIOLATION DE LA LÉGISLATION AMÉRICAINE SUR LES VALEURS MOBILIÈRES [...]

Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Efforts to Battle Opioid Epidemic

12/09/2018 - 14:00

MIAMI, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in [...]

Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT® FDA Clinical Trial

12/09/2018 - 14:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes [...]

TrakCel to develop and supply Medeor Therapeutics with cellular supply chain management and orchestration system

12/09/2018 - 14:00

CARDIFF, United Kingdom, Sept. 12, 2018 (GLOBE NEWSWIRE) -- TrakCel, the cell and gene therapy supply chain tracking and orchestration system software developer, today announces it has been engaged to build a custom- [...]

XBiotech Announces Addition of World Leading Cardiologist Dr. Peter Libby to its Scientific Advisory Board

12/09/2018 - 14:00

AUSTIN, Texas, Sept. 12, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) is pleased to announce the appointment of Peter Libby, MD to its Scientific Advisory Board (SAB). Dr. Libby will work with XBiotech to help [...]

Immunomedics and Samsung BioLogics Announce Strategic Manufacturing Partnership

12/09/2018 - 14:00

Partnership Involves Commercial-scale Production of hRS7, the Antibody Used in Immunomedics’ Lead Antibody-Drug Conjugate, Sacituzumab Govitecan MORRIS PLAINS, N.J. and INCHEON, South Korea, Sept. 12, 2018 (GLOBE [...]

Athenex and its Collaborative Partner, Hanmi Pharmaceutical, Announce Strategic Realignment of their Joint Projects

12/09/2018 - 14:00

BUFFALO, N.Y., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Emblem signs supply agreement with Aphria to purchase up to 175,000 kg equivalents of cannabis products over five years

12/09/2018 - 14:00

TORONTO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis [...]

Actor Jeremy Miller Appears on Local ABC News Supporting BioCorRx Recovery Program

12/09/2018 - 13:43

ANAHEIM, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today [...]

MRI Interventions to Present at Sidoti & Co. 2018 Fall Conference on Sept 27

12/09/2018 - 13:30

LOS ANGELES, Sept. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC), announced today that Chief Executive Officer Joe Burnett will present at the Sidoti & Co. 2018 Fall Conference on Thursday, [...]

Apellis Pharmaceuticals Announces First Patient Dosed in Its Phase 3 Clinical Program for APL-2 in Patients With Geographic Atrophy

12/09/2018 - 13:30

CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Helix BioPharma Corp. collaborator ProMab Biotechnologies Publishes Paper on Multiple Myeloma CAR-T

12/09/2018 - 13:30

RICHMOND HILL, Ontario, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP), (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Trillium Therapeutics Announces Data Presentations at Upcoming Scientific Meetings

12/09/2018 - 13:00

Updated safety and efficacy data from the TTI-621 intravenous trial at the 16th Annual Discovery on Target Conference Updated data from the TTI-621 intralesional trial in patients with mycosis fungoides and Sézary [...]

RedHill Biopharma Announces Positive End-of-Phase II Meeting with FDA on BEKINDA® for IBS-D

12/09/2018 - 13:00

The positive Type B meeting with the FDA followed a successful Phase II study of BEKINDA ® for diarrhea-predominant irritable bowel syndrome (IBS-D), one of the most common gastrointestinal disorders In light of the [...]

Asterias Provides 24 Month Cohort 2 Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury

12/09/2018 - 13:00

FREMONT, Calif., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions [...]